Encouraged by the observation that the combination treatment potentiates the RIG-I activation in KRAS mutant-driven cancer cells, we investigated the infiltration of human peripheral blood mononuclear cells (PBMCs) into the cancer spheroids after the treatment (Figure 3A). This evidence concerns the gene RIGI and cancer.